These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2531549)

  • 1. Renal vascular responses and eicosanoid release in diabetic rats.
    Sarubbi D; McGiff JC; Quilley J
    Am J Physiol; 1989 Nov; 257(5 Pt 2):F762-8. PubMed ID: 2531549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.
    Chen YJ; Li J; Quilley J
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2305-12. PubMed ID: 18326808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat.
    Li J; Chen YJ; Quilley J
    J Pharmacol Exp Ther; 2005 Aug; 314(2):818-24. PubMed ID: 15879008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat.
    Chen YJ; Li J; Quilley J
    Eur J Pharmacol; 2006 Jul; 541(1-2):80-6. PubMed ID: 16753143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucocorticoids on vascular reactivity to vasoactive hormones in rat isolated kidney: lack of relationship to prostaglandins.
    Cooper CL; Malik KU
    Br J Pharmacol; 1984 Jul; 82(3):679-88. PubMed ID: 6589024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
    Dharmani M; Mustafa MR; Achike FI; Sim MK
    Eur J Pharmacol; 2007 Apr; 561(1-3):144-50. PubMed ID: 17320855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney.
    Quilley J; Chen YJ
    Hypertension; 2003 Oct; 42(4):837-43. PubMed ID: 12900435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension.
    Bivol LM; Vågnes OB; Iversen BM
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F393-400. PubMed ID: 15784843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of glomerular and mesangial prostaglandin synthesis and glomerular contraction in two rat models of diabetes mellitus.
    Barnett R; Scharschmidt L; Ko YH; Schlondorff D
    Diabetes; 1987 Dec; 36(12):1468-75. PubMed ID: 3119406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.
    Handa RK; Strandhoy JW; Buckalew VM
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F108-16. PubMed ID: 1907104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ANG II in eicosanoid production by isolated glomeruli from rats with bilateral ureteral obstruction.
    Yanagisawa H; Morrissey J; Morrison AR; Purkerson ML; Klahr S
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F85-93. PubMed ID: 2154128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal vascular effects of angiotensin II, arginine-vasopressin and bradykinin in rats: interactions with prostaglandins.
    Hofbauer KG; Dienemann H; Forgiarini P; Stalder R; Wood JM
    Gen Pharmacol; 1983; 14(1):145-7. PubMed ID: 6826026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential response of renin secretion to vasoconstrictors in the isolated perfused rat kidney.
    Scholz H; Kaissling B; Inagami T; Kurtz A
    J Physiol; 1991 Sep; 441():453-68. PubMed ID: 1816382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction.
    Vazquez B; Rios A; Escalante B
    Life Sci; 1995; 56(18):1455-66. PubMed ID: 7752810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal prostaglandin efflux induced by vasopressin, dDAVP and arachidonic acid: contrasting profile and sites of release.
    Miller MJ; Westlin WF; McNeill H; McGiff JC
    Clin Exp Pharmacol Physiol; 1986 Aug; 13(8):577-84. PubMed ID: 3791710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal vascular interaction of angiotensin II and prostaglandins in renovascular hypertension.
    Cruz BV; Escalante B
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):21-7. PubMed ID: 10413062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase.
    Cavarape A; Bauer J; Bartoli E; Endlich K; Parekh N
    Nephrol Dial Transplant; 2003 Sep; 18(9):1764-9. PubMed ID: 12937222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II.
    Oyekan A; Balazy M; McGiff JC
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R293-300. PubMed ID: 9249563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension.
    Cediel E; Vázquez-Cruz B; Navarro-Cid J; de las Heras N; Sanz-Rosa D; Cachofeiro V; Lahera V
    Kidney Int Suppl; 2002 Dec; (82):S2-7. PubMed ID: 12410847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.